DK217585A - Farmaceutisk middel til behandling af neoplastiske sygdomstilstande - Google Patents

Farmaceutisk middel til behandling af neoplastiske sygdomstilstande Download PDF

Info

Publication number
DK217585A
DK217585A DK217585A DK217585A DK217585A DK 217585 A DK217585 A DK 217585A DK 217585 A DK217585 A DK 217585A DK 217585 A DK217585 A DK 217585A DK 217585 A DK217585 A DK 217585A
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical agent
neoplastic diseases
neoplastic
diseases
Prior art date
Application number
DK217585A
Other languages
English (en)
Other versions
DK217585D0 (da
Inventor
Nellikunja J Prakash
Sai P Sunkara
David M Stemerick
Michael L Edwards
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK217585D0 publication Critical patent/DK217585D0/da
Publication of DK217585A publication Critical patent/DK217585A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK217585A 1984-05-17 1985-05-15 Farmaceutisk middel til behandling af neoplastiske sygdomstilstande DK217585A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61122584A 1984-05-17 1984-05-17
US71848385A 1985-04-04 1985-04-04

Publications (2)

Publication Number Publication Date
DK217585D0 DK217585D0 (da) 1985-05-15
DK217585A true DK217585A (da) 1985-11-18

Family

ID=27086467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK217585A DK217585A (da) 1984-05-17 1985-05-15 Farmaceutisk middel til behandling af neoplastiske sygdomstilstande

Country Status (7)

Country Link
EP (1) EP0162413A2 (da)
AU (1) AU567613B2 (da)
DK (1) DK217585A (da)
GR (1) GR851199B (da)
HU (1) HUT40564A (da)
NZ (1) NZ212053A (da)
PH (1) PH22351A (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342945A (en) * 1986-12-02 1994-08-30 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5753714A (en) * 1987-02-03 1998-05-19 Merrell Pharmaceuticals Inc. Polyamine derivatives
AU602186B2 (en) * 1987-02-03 1990-10-04 Merrell Dow Pharmaceuticals Inc. Novel polyamine derivatives
ZA887410B (en) * 1987-10-08 1989-06-28 Merrell Dow Pharma Polyamine derivatives as antineoplastic agents
ZA903804B (en) * 1989-05-23 1991-03-27 Merrell Dow Pharma A method of potentiating cell-mediated immunity utilizing polyamine derivatives
US5719193A (en) * 1989-05-23 1998-02-17 Merrell Pharmaceuticals, Inc. Method of potentiating cell-mediated immunity utilizing polyamine derivatives
US5561136A (en) * 1990-12-13 1996-10-01 Merrell Pharmaceuticals Inc. Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
FR2706254B1 (fr) * 1993-06-17 1995-08-25 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines.
FR2706255B1 (fr) * 1993-06-17 1995-10-27 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
US5516807A (en) * 1994-10-25 1996-05-14 Warner-Lambert Company Method for treating vascular proliferative disorders following balloon angioplasty
US6166079A (en) * 1996-09-25 2000-12-26 Board Of Regents, The University Of Texas System DFMO for the treatment or prevention of cervical intraepithelial neoplasia
US6235794B1 (en) * 1997-04-03 2001-05-22 University Of Florida Biologically active spermidine analogues, pharmaceutical compositions and methods of treatment
US8198334B2 (en) 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
US7087648B1 (en) 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
ES2271000T3 (es) 2000-03-24 2007-04-16 Mediquest Therapeutics, Inc. Analogos de la poliamina como agentes citotoxicos.
WO2002102414A1 (en) * 2001-06-14 2002-12-27 Otsuka Pharmaceutical Co., Ltd. Medicinal compositions
WO2003013245A1 (en) 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
WO2012151554A1 (en) * 2011-05-04 2012-11-08 President And Fellows Of Harvard College Polyamines for treating biofilms
CN104072624B (zh) * 2014-05-15 2016-05-18 温州医科大学 一种多胺改性高分子药物及其制备方法与作为抗肿瘤药物的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1705783A (en) * 1982-06-16 1984-01-16 Intreprinderea De Medicamente "Biofarm" Medicine for the treatment of the neoplazic disease

Also Published As

Publication number Publication date
DK217585D0 (da) 1985-05-15
AU4249885A (en) 1985-11-21
AU567613B2 (en) 1987-11-26
EP0162413A2 (en) 1985-11-27
PH22351A (en) 1988-08-12
HUT40564A (en) 1987-01-28
NZ212053A (en) 1988-02-29
GR851199B (da) 1985-11-25

Similar Documents

Publication Publication Date Title
DK217585D0 (da) Farmaceutisk middel til behandling af neoplastiske sygdomstilstande
DK99086A (da) Farmaceutiske praeparater til behandling af hukommelsesforstyrrelser
DK545088A (da) Doseringsform til behandling af kardiovaskulaere sygdomme
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK76185A (da) Forbedrede praeparater til behandling af psoriasis
DK369385A (da) Middel til behandling af schizofreni
DK83683A (da) Farmaceutiske praeparater til behandling af hud
DK360884D0 (da) Farmaceutiske og veterinaere midler til behandling af iskaemiskehjertelidelser
DK473885D0 (da) Farmaceutisk middel til lokal behandling af psoriasis
DK10188A (da) Middel til behandling af virussygdomme
DK632388D0 (da) Pharmaceutisk middel til behandling af hypolipidaemi hos pattedyr
DK322683A (da) Middel til behandling af saar
DK228381A (da) Fremgangsmaade til fremstilling af antidiarretiske farmaceutiske praeparater
DK357186A (da) Ikke-irriterende middel til behandling af dyrs patter
IT1151104B (it) Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici
DK441987D0 (da) Farmaceutisk praeparat til behandling af cerebral ischaemi
DK162146C (da) Pesticidt middel til behandling af trae
DK551683D0 (da) Middel til behandling af gastroinflammationssygdomme
FI831258L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara benzimidazolderivat
DK39584D0 (da) Anvendelse af nafazatrom til forebyggelse og behandling af diverse sygdomme, laegemidler indeholdende nafazatrom sa mt fremgangsmader til disses fremstilling
DK639088A (da) Laegemiddel til behandling af iskaemiske hjertesygdomme
DK305289A (da) Apparat til behandling af reumatiske sygdomme
RO81791A2 (ro) Comprimate pentru tratamentul uremiilor feriprive
IT8321614A0 (it) Medicina per il trattamento di affezione neoplastica.
DK461983D0 (da) Fremgangsmade til intravenoes dosering af medikamenter